Gilgamesh Pharma raises $39 million to combat depression, mental illness
Gilgamesh Pharmaceuticals is a Y Combinator alumnus that is working to develop a new type of psychedelic medicine that has…
Gilgamesh Pharmaceuticals is a Y Combinator alumnus that is working to develop a new type of psychedelic medicine that has…
